Bio Plus Co., Ltd (KOSDAQ:099430)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,575.00
-120.00 (-2.56%)
Jun 10, 2026, 3:30 PM KST

Bio Plus Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
13,99615,00114,15125,58121,13710,725
Depreciation & Amortization
4,4544,0633,2702,4901,8871,298
Loss (Gain) From Sale of Assets
35.5335.53-592.748.52109.06-
Asset Writedown & Restructuring Costs
74.4974.49---1,565
Loss (Gain) From Sale of Investments
-302.57-326.27-87.62-41.03-639.04-
Loss (Gain) on Equity Investments
202.42178.28--311.08327.99
Stock-Based Compensation
--66.39188.3945035.98
Provision & Write-off of Bad Debts
4,8894,2821,5501,025-265.58268.08
Other Operating Activities
-516.46-269.535,913-2,6622,8283,176
Change in Accounts Receivable
2,275939.544,601-5,255-8,671-3,628
Change in Inventory
-5,087-5,705-1,4922,339-4,158-66.02
Change in Accounts Payable
-698.57-392.16403.41-717.63157.89219.49
Change in Unearned Revenue
----260--
Change in Income Taxes
-101.99-79.8-29.01-0.11-0.21-
Change in Other Net Operating Assets
-1,938-147.27-1,267-2,408213.89-569.51
Operating Cash Flow
17,28117,65526,48720,28913,35913,352
Operating Cash Flow Growth
-13.00%-33.34%30.55%51.87%0.05%32.95%
Capital Expenditures
-30,749-46,582-94,999-21,092-6,530-15,312
Sale of Property, Plant & Equipment
14141,048-5-
Cash Acquisitions
-34.16-34.16----
Divestitures
--76.022,103-0.29
Sale (Purchase) of Intangibles
-1,167-1,346-1,143-479.64-164.26-46.05
Investment in Securities
-2,728-1,42412,77241,181-60,360-5,700
Other Investing Activities
-1,285-150.27-150.24-67.83-121.16-212.24
Investing Cash Flow
-35,955-49,528-84,36421,728-67,130-22,634
Short-Term Debt Issued
-4,0768,196---
Long-Term Debt Issued
-1,87759,699---
Total Debt Issued
18,0525,95267,896---
Short-Term Debt Repaid
--4,261-3,556-1,040--274.38
Long-Term Debt Repaid
--1,286-820.78-715.04-612.77-289.99
Total Debt Repaid
-15,127-5,547-4,377-1,755-612.77-564.37
Net Debt Issued (Repaid)
2,925405.5263,519-1,755-612.77-564.37
Issuance of Common Stock
9,86810,359-30012,47845,500
Repurchase of Common Stock
-1,499-1,499-4,990-4,990-1,186-8,793
Common Dividends Paid
-2,916-2,916-4,197-4,249--
Other Financing Activities
236.75341.06-350-3,767-15-2,098
Financing Cash Flow
16,07514,15149,522-14,46130,65934,045
Foreign Exchange Rate Adjustments
-3.21156.891,02395.82434.57271.96
Miscellaneous Cash Flow Adjustments
00-0-0-00
Net Cash Flow
-2,603-17,565-7,33127,653-22,67725,035
Free Cash Flow
-13,468-28,927-68,513-803.376,829-1,959
Free Cash Flow Margin
-14.26%-31.82%-103.17%-1.23%12.04%-5.24%
Free Cash Flow Per Share
-195.60-422.81-1195.85-13.26119.07-37.80
Cash Interest Paid
165.76172.54128.25146.055.8851.21
Cash Income Tax Paid
2,3362,3654,6178,3772,8932,863
Levered Free Cash Flow
-30,551-70,135-36,701-5,0841,141-6,383
Unlevered Free Cash Flow
-30,357-69,945-36,536-5,0461,149-6,057
Change in Working Capital
-5,551-5,3852,217-6,300-12,458-4,044